Brainlab multiple metastases planning software available in the USA


Brainlab has announced 510(k) clearance for two software modules for radiation oncologists and neurosurgeons. Adaptive Hybrid Surgery and Automatic Brain Metastases Planning software by Brainlab are now available in the USA after successful clinical use in several international markets.

Brainlab’s Adaptive Hybrid Surgery helps physicians to balance surgical risk with radiosurgical toxicity for multi-disciplinary treatment of skull-base tumours. A complete set of automated tools enables analysis of adjuvant radiosurgery at any time, while planning and performing a surgical resection. Elements Intraoperative Structure Update captures residual tumour volumes based on points acquired inside the resection cavity. An intuitive traffic light display provides comprehensive information about tumour coverage and critical dose constraints for calculated treatment plans.

The Automatic Brain Metastasis Planning software introduces the market to technology that consistently and rapidly generates radiosurgery plans for the efficient treatment of multiple metastases. This breakthrough technology allows clinicians to plan and treat multiple brain metastases with time and dose efficiencies while helping to minimise exposure to healthy surrounding tissue. Treatment delivery and planning time can be reduced drastically, even for as many as 10 metastatic tumours in the brain.

“We expect [our new software’s] capabilities, efficiency and usability to help change the way certain life-threatening diseases are treated,” comments Stefan Vilsmeier, president and chief executive officer of Brainlab.